Search - tctmd.com

Displaying 161 - 180 of 210

Sort: Relevancy | Date

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Conference News SCAI 2019

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Yael L. Maxwell

May 22, 2019

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Todd Neale

September 13, 2018

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Todd Neale

July 02, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

Advertisement

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

One in Two Americans Have Cardiovascular Disease: AHA Stats

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content